Alibaba Health Information TechnologyALBHF +2.44%55 Return-on-Tangible-Equity is 8.18% as of Mar. 2026, which is 367% above its 10-year median of 1.75. GuruFocus rates ALBHF with a GF Score™ of 55/100 and a GF Value™ of $0.67 (Significantly Undervalued). The stock has 2 warning signs investors should review. Among 579 Healthcare Providers & Services companies, Alibaba Health Information Technology ranks better than 53.89% on this metric.
The historical rank and industry rank for Alibaba Health Information Technology's Return-on-Tangible-Equity or its related term are showing as below:
ALBHF'
s Return-on-Tangible-Equity Range Over the Past 10 Years
Min: -16.93 Med: 1.75 Max: 12.42
Current: 12.04
During the past 13 years, Alibaba Health Information Technology's highest Return-on-Tangible-Equity was 12.42%. The lowest was -16.93%. And the median was 1.75%.
ALBHF's Return-on-Tangible-Equity is ranked better than 53.89% of 579
companies
in the Healthcare Providers & Services industry
Industry Median: 10.13
vs ALBHF: 12.04
Alibaba Health Information Technology (OTCPK:ALBHF) Return-on-Tangible-Equity Explanation
Return-on-Tangible-Equity measures the rate of return on the ownership interest (shareholder's tangible equity) of the common stock owners. It measures a firm's efficiency at generating profits from every unit of shareholders' tangible equity (shareholders equity minus intangibles). Return-on-Tangible-Equity shows how well a company uses investment funds to generate earnings growth. Return-on-Tangible-Equitys between 15% and 20% are considered desirable.
Be Aware
Net Income is used.
Because a company can increase its Return-on-Tangible-Equity by having more financial leverage, it is important to watch the leverage ratio when investing in high Return-on-Tangible-Equity companies. Like Return-on-Tangible-Asset, Return-on-Tangible-Equity is calculated with only 12 months data. Fluctuations in company's earnings or business cycles can affect the ratio drastically. It is important to look at the ratio from a long term perspective.
Asset light businesses require very few assets to generate very high earnings. Their Return-on-Tangible-Equitys can be extremely high.
Alibaba Health Information Technology Return-on-Tangible-Equity Related Terms
Alibaba Health Information Technology Return-on-Tangible-Equity Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Alibaba Health Information Technology Return-on-Tangible-Equity Chart
Alibaba Health Information Technology Return-on-Tangible-Equity Competitor Comparison
For the Pharmaceutical Retailers subindustry, Alibaba Health Information Technology's Return-on-Tangible-Equity, along with its competitors' market caps and Return-on-Tangible-Equity data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Alibaba Health Information Technology Return-on-Tangible-Equity vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, Alibaba Health Information Technology's Return-on-Tangible-Equity distribution charts can be found below:
* The bar in red indicates where Alibaba Health Information Technology's Return-on-Tangible-Equity falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
In the calculation of annual Return-on-Tangible-Equity, the net income of the last fiscal year and the average total shareholder tangible equity over the fiscal year are used. In calculating the quarterly data,
the net income data used here is two times the semi-annual (Mar. 2026) net income data.
Return-on-Tangible-Equity is displayed in the 10-year financial page.
What does a Return-on-Tangible-Equity of 8.18% mean?
Alibaba Health Information Technology (ALBHF) has a Return-on-Tangible-Equity of 8.18% as of Mar. 2026. Return on tangible equity is the ratio of current-period net income to average two-period tangible equity. View historical data on Alibaba Health Information Technology and its competitors. This is 367% above median its historical median of 1.75. According to the industry distribution chart, Alibaba Health Information Technology ranks #267 out of 579 companies in the Healthcare Providers & Services industry, placing it in the top 46.1%.
Is Alibaba Health Information Technology's Return-on-Tangible-Equity too high?
Alibaba Health Information Technology's current Return-on-Tangible-Equity of 8.18% is 367% above median its 10-year median of 1.75. The Healthcare Providers & Services industry median Return-on-Tangible-Equity is 10.13. Alibaba Health Information Technology's value of 8.18% is 19.2% below this industry median. Based on the distribution chart, Alibaba Health Information Technology ranks #267 out of 579 companies in the Healthcare Providers & Services industry, which is above the industry midpoint. Overall, Alibaba Health Information Technology has a GF Score™ of 55/100 and is considered Significantly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Alibaba Health Information Technology's Return-on-Tangible-Equity compare to competitors?
According to the Healthcare Providers & Services industry distribution chart, Alibaba Health Information Technology ranks #267 out of 579 companies for Return-on-Tangible-Equity. This puts Alibaba Health Information Technology in the upper half of its industry. The industry median Return-on-Tangible-Equity is 10.13. Alibaba Health Information Technology's value of 8.18% is 19.2% below this benchmark. While the company's 10-year median is 1.75 vs. the industry median of 10.13, Alibaba Health Information Technology has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Return-on-Tangible-Equity for a Healthcare Providers & Services company?
The median Return-on-Tangible-Equity among Healthcare Providers & Services companies is 10.13, based on 579 companies in the industry. Companies in the top quartile (top 25%) have a Return-on-Tangible-Equity significantly above this median, while those in the bottom quartile fall well below. However, Return-on-Tangible-Equity should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Alibaba Health Information Technology's current Return-on-Tangible-Equity of 8.18% is 19.2% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Return-on-Tangible-Equity mean?
A high Return-on-Tangible-Equity can signal that a stock is expensive relative to its fundamentals. Return on tangible equity is the ratio of current-period net income to average two-period tangible equity. View historical data on Alibaba Health Information Technology and its competitors. For the Healthcare Providers & Services industry, the median Return-on-Tangible-Equity is 10.13 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Alibaba Health Information Technology's current Return-on-Tangible-Equity is 8.18%, which is 367% above median its own 10-year median of 1.75. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Alibaba Health Information Technology stock overvalued right now?
Based on GuruFocus' analysis, Alibaba Health Information Technology (ALBHF) is currently considered Significantly Undervalued. The stock's GF Value™ is $0.67, compared to a current price of $0.42 — trading 37.3% below its estimated fair value. The current Return-on-Tangible-Equity is 8.18%, which is 367% above median its 10-year median of 1.75 and 19.2% below the Healthcare Providers & Services industry median of 10.13. Alibaba Health Information Technology's overall GF Score™ is 55/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Return-on-Tangible-Equity calculated?
Return-on-Tangible-Equity is calculated from a company's financial statements. For Alibaba Health Information Technology (ALBHF), the current Return-on-Tangible-Equity is 8.18% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Alibaba Health Information Technology (ALBHF) Overvalued in 2026?
Based on GuruFocus' analysis, Alibaba Health Information Technology stock appears to be undervalued.
The current stock price of $0.42 is trading 37.3% below its estimated GF Value™ of $0.67.
GuruFocus considers Alibaba Health Information Technology to be Significantly Undervalued.
Key valuation signals for ALBHF:
Return-on-Tangible-Equity: 8.18% (367% above median its 10-year median of 1.75)
GF Value™: $0.67 vs. price of $0.42 (37.3% below fair value)
Industry Position: 19.2% below the Healthcare Providers & Services median (#267 of 579)
No single metric tells the full story. See the ALBHF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Alibaba Health Information Technology Business Description
Alibaba Health is of one of China's leading e-commerce platform specializing in healthcare-related products, including prescription drugs, OTC drugs, traditional Chinese medicine, health foods, and so on. The company operates both a third-party B2C service, or 3P, and its own direct-to-consumer business, or 1P, with its own inventory, which can both be accessed by Alibaba's Tmall app and Alipay. The company also provides online consultation services in a separate app although its e-commerce businesses remain its core competency in the long-term. E-commerce accounted for 93% of revenue in fiscal year 2022. We estimate that AliHealth holds about 45% of market share in the industry in terms of GMV. AliHealth is 63.74% owned by its parent company, Alibaba Group.
55GF Score
Get the complete analysis for ALBHF
Return-on-Tangible-Equity is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
ALBHF has been successfully added to your 
